Get started
Author

Diego Carbonell

Observed names: Carbonell, D., D. Carbonell, Diego Carbonell Muñoz
ORCID: 0000-0003-2960-0301
Observed ORCID: 0000-0003-2960-0301
OpenAlex ID: A5037322285
Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel
2022 · Reyes Maria Martín‐Rojas, Ignacio Gómez‐Centurión, et al. · Clinical Case Reports · 48
PDF
Donor Cell–Derived Hematologic Neoplasms after Hematopoietic Stem Cell Transplantation: A Systematic Review
2018 · Julia Suárez-González, Carolina Martínez-Laperche, et al. · Transplantation and Cellular Therapy · 43
PDF
Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms
2019 · Diego Carbonell, Julia Suárez-González, et al. · Cancers · 40
PDF
ICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profiling
2025 · Marina Gomez-Llobell, Carlos Serra Smith, et al. · Bone Marrow Transplantation · 37
PDF
Short Tandem Repeats (STRs) as Biomarkers for the Quantitative Follow-Up of Chimerism after Stem Cell Transplantation: Methodological Considerations and Clinical Application
2020 · Almudena Navarro-Bailón, Diego Carbonell, et al. · Genes · 37
PDF
Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals
2022 · Sergio Gil-Manso, Iria Miguens Blanco, et al. · Frontiers in Immunology · 31
Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation
2022 · Paula Muñiz, Cristina Andrés-Zayas, et al. · Frontiers in Immunology · 30
EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
2022 · C. Martínez-Laperche, L. Sanz-Villanueva, et al. · BMC Cancer · 27
PDF
ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2
2021 · Sergio Gil-Manso, Iria Miguens Blanco, et al. · Virulence · 27
Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days
2021 · Sergio Gil-Manso, Diego Carbonell, et al. · Frontiers in Immunology · 26
PDF
ST2 and REG3α as Predictive Biomarkers After Haploidentical Stem Cell Transplantation Using Post-transplantation High-Dose Cyclophosphamide
2019 · Laura Solán, Mi Kwon, et al. · Frontiers in Immunology · 24
PDF
Multidimensional analysis of immune cells from COVID-19 patients identified cell subsets associated with the severity at hospital admission
2023 · Sergio Gil-Manso, Diego Herrero-Quevedo, et al. · PLoS Pathogens · 18
PDF
Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide
2021 · Laura Solán, Diego Carbonell, et al. · Frontiers in Immunology · 18
PDF
Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide
2021 · Paula Muñiz, Mi Kwon, et al. · Frontiers in Immunology · 17
PDF
Whole-exome sequencing reveals acquisition of mutations leading to the onset of donor cell leukemia after hematopoietic transplantation: a model of leukemogenesis
2018 · Julia Suárez-González, Carolina Martínez-Laperche, et al. · Leukemia · 17
Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients
2024 · Ismael de la Iglesia-San Sebastián, Diego Carbonell, et al. · Transplantation and Cellular Therapy · 15
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide
2023 · Ignacio Gómez-Centurión, Reyes Maria Martin Rojas, et al. · Annals of Hematology · 15
Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms
2022 · Miren Vallejo, Paula Muñiz, et al. · Annals of Hematology · 13
PDF
The Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma
2025 · Roberto García-Vicente, Alba Rodríguez-García, et al. · Clinical Cancer Research · 12
Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin’s lymphoma
2021 · Mariana Bastos-Oreiro, Julia Suárez-González, et al. · Scientific Reports · 12
PDF
Allogeneic CD34 ‐selected stem cell boost as salvage treatment of life‐threatening infection and severe cytopenias after CAR‐T cell therapy
2022 · Pablo Silva de Tena, Rebeca Bailén, et al. · Transfusion · 9
Cellular and Humoral Responses Follow-up for 8 Months after Vaccination with mRNA-Based Anti-SARS-CoV-2 Vaccines
2022 · Sergio Gil-Manso, Diego Carbonell, et al. · Biomedicines · 8
PDF
Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition
2021 · Cristina Andrés‐Zayas, Julia Suárez‐González, et al. · Molecular Oncology · 8
PDF
Enhancing CAR-T Cell Therapy for Non-Hodgkin Lymphoma through Gut Microbiota and Butyrate
2024 · Roberto Garcia-Vicente, Alba Rodríguez García, et al. · Blood · 7
PDF
Cell-Free DNA Dynamic Concentration and Other Variables Are Predictors of Early Progression after Chimeric Antigen Receptor T Cell Therapy in Patients with Diffuse Large B Cell Lymphoma
2023 · Mariana Bastos-Oreiro, Laura Sanz-Villanueva, et al. · Transplantation and Cellular Therapy · 7
Works count: 60
Citation count: 575
H-index: 15
I10-index: 20
Year
Topic
Type